> All News
> BASL News
> Hepatology News
> Nurse News
> Trainee News
> Transplant News
News Articles 1 - 10 of 160
This is for a Clinical Research Fellow in Hepatology to be supervised by Dr Richard Aspinall in Portsmouth.
The post is for an initial 12 months with the expectation to extend to 2 or 3 years if desired.
In addition to helping deliver NIHR portfolio studies, the research fellow will be supported to develop an investigator led project subject to their interests and register for a higher degree. Potential projects are negotiable but existing opportunities include alcohol related illness, NAFLD/NASH, portal hypertension, polycystic liver disease, renal dysfunction in cirrhosis and ongoing collaborations with Public Health.
Informal enquiries are welcomed. Please contact Dr Richard Aspinall, NIHR Wessex Research Network Lead for Hepatology by email firstname.lastname@example.org or telephone 02392 28 6255.
The link to the NHS Jobs advert is here:
Closing date is 31/05/21
Gilead Sciences has announced the launch of a global grant program to support investigator-sponsored research within HDV; HDV DESCRIBE (HDV Epidemiology, Screening and Barriers to Linkage to Care).
The program seeks to better understand HDV patient populations, epidemiology, screening practices and cascades of care.
The program will support individual projects up to $150,000 USD or equivalent sum; projects greater than $150,000 will require approval by Gilead prior to submission.
Successful projects should be able to be completed within 12 months and demonstrate clear objectives, defined timelines, a comprehensive operational plan, and propose data that has relevance to the medical community and policy makers. Priority will be given to studies exploring regional data.
Further information can be read in the program description document available below:
Download Gilead HDV DESCRIBE RFP program description_May2021.pdf
The program will be accepting Letters of Interest between 3rd May and 4th June 2021.
If you have any questions please contact Joyeta.Das@gilead.com .
(Added 4th May 2021)
Main area – Hepatology and Liver Transplantation
Grade – Clinical Fellow (Higher-Senior)
Contract – 12 months (Fixed Term) from 6th September 2021
Hours – Full Time
Job ref - 180-CFH-3673 - for full details click > here.
Employer - Cambridge University Hospitals NHS Foundation Trust
Employer Type - NHS
Salary - £50,017 - £55,790 Per annum
Closing date - 23/05/2021 23:59
For further information contact Dr Victoria Snowdon, Consultant Hepatologist/ Postgraduate Lead for Hepatology - email@example.com .
Guts UK are delighted to announce that Guts UK/BSPGHAN Grants are now open.
Guts UK and the British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) are passionate about supporting research into paediatric gastrointestinal, hepatological and nutritional disorders. Since 2010 we have joined forces to co-fund a biennial grant call.
Guts UK and BSPGHAN have just opened a new grant call to provide financial support for the collection of pilot or proof-of-concept data that will enable a high-quality competitive application to be made subsequently to a research council or other large funder.
Clinician and scientific investigators, including academic clinical lecturers, based at a UK university or hospital may apply. The principal applicant must have a contract of sufficient length to cover the duration of the research project and must have their salary guaranteed for the duration.
One grant, worth up to £40,000 is available for up to two years to fund direct costs associated with the project. Click here for further information.
The deadline is 1st June 2021. Please direct any queries to firstname.lastname@example.org
The Guts UK/Dr Falk awards recognise the achievements of those who bring new knowledge and insight to the field of gastroenterology, pancreatology and hepatology. These awards are an opportunity to achieve national recognition as well as the financial support for career progression.
A £1,000 prize for the best essay on gastroenterology or hepatology research personally undertaken by medical students who were on an intercalated BSc/MRes/MSc/MPH/MBPhD* course during the previous academic year (2019-20).
Four £1,500 prizes for medical students taking full-time science degrees (BSc/MRes/MSc/MPH/MBPhD*) focusing on gastrointestinal or liver-related disease in the current academic year (2020-21).
Two £2,500 awards for F1/F2 doctors to facilitate prospective research in an area relevant to gastroenterology or hepatology.
A £1,000 award for primary and secondary care gastrointestinal/liver nurses for initiatives that have improved patient care. (Nominate your colleague today for this award).
A £1,000 award for dietitians working in gastroenterology or hepatology for initiatives that have improved patient care.
Up to £10,000 is available for UK-based gastroenterology / hepatology SpR trainees who would like to conduct an audit or quality improvement project in any area of gastroenterology, liver disease or nutrition.
Applications close at 17:00 on April 12th April 2021
For further information and to apply: https://gutscharity.org.uk/research/grants-and-awards/the-guts-uk-dr-falk-awards/
* PhD students should note that they may apply for the medical student prize only once during their three-year studentship and that they may apply for the essay prize when their PhD has been completed.
Specialty/Department: Department of Hepatology
Location: Leeds Liver Unit, St James’s University Hospital
Salary: Dependent on Experience
Closes: midnight on 09/03/2021
Applications are invited for a Clinical Fellowship as part of a locum appointment for service available for up to 12 Months in the Department of Hepatology at St James’s University Hospital in Leeds. The post is available immediately but flexible for the right candidate.
We are looking for an enthusiastic well-motivated trainee who wants the opportunity to gain experience in the management of liver disease.
With a growing need for doctors to understand and be able to manage patients with liver disease, this is an exciting opportunity to train in one of the leading UK Hepatology centres and contribute to the Leeds Liver Unit’s international reputation for transplantation.
The successful candidate will gain experience in all aspects of hepatology including the assessment of patients with acute and sub-acute liver failure, assessment of patients for treatments such as liver transplantation and TIPSS, patients with a wide variety of complex general hepatological conditions and with viral hepatitis. This is a clinical post and the fellow will join the out of hours rota and have the opportunity to undertake audit and contribute to ongoing projects in the department.
The Department is affiliated to the University of Leeds with the MRC funded Centre for Bioinformatics, the Leeds Institute of Data Analysis and the NIHR funded Diagnostic Evaluation Co-operative.
Candidates should hold full license to practice with the UK General Medical Council and have completed their Foundation Years training or equivalent
Basic salary scale will depend upon experience. An out of hours banding supplement will also apply.
Interested applicants are welcome to contact Dr Mark Aldersley, Consultant Hepatologist and Lead Clinician by e-mail email@example.com .
(added 09.02.2021/amended 25.02.21)
The arrival of vaccination for Covid-19 is a very welcome development, particularly after the heavy toll on patients and liver services in 2020. However, the efficacy, or potential for adverse events, of these vaccines in patients with chronic liver disease (CLD) or post-liver transplantation (LT) remains unknown. Sub-optimal immune responses to vaccines are common in CLD and post-LT, and thus additional protective strategies may be necessary.
COBALT is a pan-European, large-scale, prospective observational cohort study designed to determine the real-world effectiveness and safety of vaccines for Covid-19 in CLD and post-LT. We invite centres to participate in this effort, co-ordinated by EF-CLIF: www.efclif.com .
Gilead’s Research Scholars Program supports innovative research from emerging investigators around the world to advance scientific knowledge in areas of unmet medical needs. Each award is funded up to $130,000 for two years, to be paid in annual installments of up to $65,000 per year.
The Research Scholars Program for liver disease is currently accepting applications from early-career scientists to support basic, clinical and translational research in the field of liver disease, including but not limited to:
• Chronic viral hepatitis
• End-stage liver disease and its complications
• Non-viral chronic liver diseases
• Hepatocellular carcinoma (HCC)
• Cholangiocarcinoma (CCC)
The program will be accepting applications until 26th February 2021.
More information on the program, including eligibility criteria and how to submit an application, can be found by visiting the following website: https://researchscholars.gilead.com/en/intl_liver_disease_portal/program-overview
All acute hospital Trusts in England, Wales and Northern Ireland will be contacted on the 18th January 2021 asking them to respond to a Survey asking about a range of aspects of care for patients with alcohol-related liver disease (ARLD).
This Survey is 10 years after the NCEPOD review of patients who died with ARLD, which made up the 2013 NCEPOD report ‘Measuring the Units’. This is an important piece of work looking at where we are with care provision for this patient group, what has improved and where there is work still to be done. For this to have the most impact, it is crucial that there is strong clinician engagement with their Trusts and we very much appreciate your support with this.
Please contact NCEPOD at firstname.lastname@example.org to be put in contact with the person at your Trust/Health board to whom the Survey has been sent.
A joint statement from British Society of Gastroenterology, British Association for the Study of the Liver, NHS Blood & Transplant and British Liver Trust.
Patients with liver disease that are considered to be clinically extremely vulnerable, and are at increased risk if they contract COVID-19. This advice refers to this group and to all other patients with liver disease.
- Whilst the vaccine trials have not looked specifically at safety in patients with liver disease, there is no data to suggest harm.
- Although vaccines may be less effective in patients with chronic liver disease and those post-liver transplant, they still provide protection. As yet there is no data specifically on the Sars-CoV2 vaccines
- We recommend that patients with chronic liver disease, autoimmune hepatitis and those post-liver transplant should consider vaccination for Sars-CoV2 with any of the available vaccines.
First published on 08 Jan 2021